Compare Mutual Funds

Pros
3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Lower expense ratio.

Lower expense ratio.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Larger AUM within category.

Larger AUM within category.

Cons

-

-

INDMoney rank
2/8
3/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

8 Years 4 Months

8 Years 3 Months

Fund AUM

₹3442 Cr

₹6803 Cr

Min Investment
  1. SIP ₹99
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.45%

1.33%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

31

38

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(10.95%)
  2. Divi's Laboratories Ltd(7.53%)
  3. J.B. Chemicals & Pharmaceuticals Ltd(6.49%)
  4. Apollo Hospitals Enterprise Ltd(6.09%)
  5. Glenmark Pharmaceuticals Ltd(6.09%)
  1. Sun Pharmaceuticals Industries Ltd(12.69%)
  2. Dr Reddy's Laboratories Ltd(8.45%)
  3. Cipla Ltd(6.56%)
  4. Divi's Laboratories Ltd(6.03%)
  5. Mankind Pharma Ltd(5.47%)
No of Sectors

2

2

Top 3 Sectors
  1. Health(98.92%)
  2. Basic Materials(1.08%)
  1. Health(98.79%)
  2. Basic Materials(1.21%)
Equity %

99.78%

97.16%

Debt %

-

-

P/E

44.05

38.49

P/B

6.17

4.35

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

1.19%

-0.3%

3-Month Return

12%

6.61%

6-Month Return

18.69%

14.01%

1-Year Return

22.49%

10.78%

3-Year Return

23.9%

23.54%

5-Year Return

15.67%

16.01%

Sharpe

1.04

1.03

Alpha

0.99

1.05

Beta

0.97

0.95

Standard Deviation

16.13

16.12

Information Ratio

0.19

0.1

Description

Mirae Asset Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Tanmay Mehta, Vrijesh Kasera

Sharmila D’mello, Dharmesh Kakkad

Most Popular Comparisons